|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial显示文摘 | William J Sandborn Daniel H Present Kim L Isaacs Douglas C Wolf Eugene Greenberg Stephen B Hanauer Brian G Feagan Lloyd Mayer Therese Johnson Joseph Galanko Christopher Martin Robert S Sandler | 2003 | Gastroenterology2003，，2： | 1 |
| 2 | Rim seal ex- periments and analysis for turbine applications显示文摘 | Daniels W A Johnson B W Graber D J | 1992 | Journal of Turbomachinery1992，114，2： | 1 |
| 3 | Anesthesia induces neuronal cell death in the developing rat brain via the intrinsic and extrinsic apoptotic pathways显示文摘 | YON J H DANIEL JOHNSON J CARTER L B | 2005 | Neuroscience2005，135，3： | 1 |
| 4 | Synthesis and properties of waterborne self-crosslinkable sulfo-urethane silanol dispersions 显示文摘 | Kevin Lewandowski Larry R Krepski Daniel E Mickus Ralph R Roberts Steven M Heilmann Wayne K Larson Mark D Purgett Steven D Koecher Stephen A Johnson Daniel J Mcgurran Chris J Rueb Sadanand V Pathre Khalid A M Thakur | 2002 | Journal of Polymer Science Part A : Polymer Chemistry2002，40，17： | 1 |
| 5 | Nudge your customers toward better choices显示文摘 | Goldstein Daniel G Eric J Johnson Andreas Herrmann and Mark Heitmann | 2008 | Harvard Business Review2008，86，12： | 1 |
| 6 | Cutthroat cooperation: asymmetrical adaptation to changes in team reward structures显示文摘 | JOHNSON MICHAEL D HOLLENBECK JOHN R ILGEN DANIEL R JUNDT DUSTIN MEYER CHRISTOPHER J | 2006 | Academy of Management Journal2006，490，： | 1 |
| 7 | Compact vertically stacked master oscillator power amplifier based on grating coupled laser diode 显示文摘 | Smolski O V O'Daniel J K Johnson E G | 2006 | IEEE Photonics Technology Letters2006，18，18： | 1 |
| 8 | Rim seal ex- periments and analysis for turbine applications显示文摘 | Daniels W A Johnson B V Graber D J | 1992 | Journal of Turbomachinerv1992，114，2： | 1 |
| 9 | Return to sports after shoulder arthroplasty显示文摘Many patients prioritize the ability to return to sports following shoulder replacement surgeries, including total shoulder arthroplasty(TSA), reverse total shoulder arthroplasty(RTSA), and hemiarthroplasty(HA). While activity levels after hip and knee replacements have been well-established in the literature, studies on this topic in the field of shoulder arthroplasty are relatively limited. A review of the literature regarding athletic activity after shoulder arthroplasty was performed using the PubMed database. All studies relevant to shoulder arthroplasty and return to sport were included. The majority of patients returned to their prior level of activity within six months following TSA, RTSA, and shoulder HA.Noncontact, low demand activities are permitted by most surgeons postoperatively and generally have higher return rates than contact sports or high-demand activities. In some series, patients reported an improvement in their ability to participate in sports following the arthroplasty procedure. The rates of return to sports following TSA(75%-100%) are slightly higher than those reported for HA(67%-76%) and RTSA(75%-85%). Patients undergoing TSA, RTSA, and shoulder HA should be counseled that there is a high probability that they will be able to return to their preoperative activity level within six months postoperatively. TSA has been associated with higher rates of return to sports than RTSA and HA,although this may reflect differences in patient population or surgical indication. | Christine C Johnson Daniel J Johnson Joseph N Liu Joshua S Dines David M Dines Lawrence V Gulotta Grant H Garcia | 2016 | World Journal of Orthopedics2016，7，9： | 1 |
| 10 | Abiotic factors limiting photosynthesis in Abies lasiocarpa and Picea engelmannii seedlings below and above the alpine timberline显示文摘 | Daniel M Johnson Matthew J Germino Williamk Smith | 2004 | Tree Physiol2004，，4： | 1 |
| 11 | Geochemistry of barium in marine sediments: implications for its use as a paleoproxy显示文摘 | James McManus William M Berelson Gary P Klinkhammer Kenneth S Johnson Kenneth H Coale Robert F Anderson Niraj Kumar David J Burdige Douglas E Hammond Hans J Brumsack Daniel C McCorkle Ahmed Rushdi | 1998 | Geochimica et Cosmochimica Acta1998，，： | 1 |
| 12 | Nudge your customers toward better choices显示文摘 | Goldstein Daniel G Johnson E J | 2008 | Harvard Business Review2008，86，12： | 1 |
| 13 | Recurrent cyclops lesion after primary anterior cruciate ligament reconstruction using bone tendon bone allograft:A case report显示文摘BACKGROUND Cyclops lesions are a known complication of anterior cruciate ligament(ACL)reconstruction,with symptomatic cyclops syndrome occurring in up to 11%of surgeries.Recurrent cyclops lesions have been rarely documented;this case study documents the successful treatment of a recurrent cyclops lesion.CASE SUMMARY A 28-year-old female presented following a non-contact injury to the right knee.Workup and clinical exam revealed an ACL tear,and arthroscopic reconstruction was performed.Two years later a cyclops lesion was discovered and removed via arthroscopic synovectomy.Seven months postoperatively,the patient presented with pain,stiffness,and difficulty achieving terminal extension.A smaller recurrent cyclops lesion was diagnosed,and a repeat synovectomy was performed.The patient recovered fully.CONCLUSION To the best of our knowledge,this is the first documented case of recurrent cyclops lesion after bone-patellar tendon-bone allograft ACL reconstruction presenting as cyclops syndrome. | Grayson Kelmer Andrea H Johnson Justin J Turcotte Daniel E Redziniak | 2023 | World Journal of Orthopedics2023，14，11： | 0 |
| 14 | Health-related quality-of-life and health-utility reporting in critical care显示文摘Mortality is a well-established patient-important outcome in critical care studies.In contrast,morbidity is less uniformly reported(given the myriad of critical care illnesses and complications of each)but may have a common end-impact on a patient’s functional capacity and health-related quality-of-life(HRQoL).Survival with a poor quality-of-life may not be acceptable depending on individual patient values and preferences.Hence,as mortality decreases within critical care,it becomes increasingly important to measure intensive care unit(ICU)survivor HRQoL.HRQoL measurements with a preference-based scoring algorithm can be converted into health utilities on a scale anchored at 0(representing death)and 1(representing full health).They can be combined with survival to calculate quality-adjusted life-years(QALY),which are one of the most widely used methods of combining morbidity and mortality into a composite outcome.Although QALYs have been use for health-technology assessment decision-making,an emerging and novel role would be to inform clinical decision-making for patients,families and healthcare providers about what expected HRQoL may be during and after ICU care.Critical care randomized control trials(RCTs)have not routinely measured or reported HRQoL(until more recently),likely due to incapacity of some patients to participate in patient-reported outcome measures.Further differences in HRQoL measurement tools can lead to non-comparable values.To this end,we propose the validation of a gold-standard HRQoL tool in critical care,specifically the EQ-5D-5L.Both combined health-utility and mortality(disaggregated)and QALYs(aggregated)can be reported,with disaggregation allowing for determination of which components are the main drivers of the QALY outcome.Increased use of HRQoL,health-utility,and QALYs in critical care RCTs has the potential to:(1)Increase the likelihood of finding important effects if they exist;(2)improve research efficiency;and(3)help inform optimal management of critically ill patients allowing for decision-making about their HRQoL,in additional to traditional health-technology assessments. | Vincent Issac Lau Jeffrey A Johnson Sean M Bagshaw Oleksa G Rewa John Basmaji Kimberley A Lewis M Elizabeth Wilcox Kali Barrett Francois Lamontagne Francois Lauzier Niall D Ferguson Simon J W Oczkowski Kirsten M Fiest Daniel J Niven Henry T Stelfox Waleed Alhazzani Margaret Herridge Robert Fowler Deborah J Cook Bram Rochwerg Feng Xie | 2022 | World Journal of Critical Care Medicine2022，11，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员